SuperGen to Present at BIO Investor Forum on October 29, 2009

• Press Release
• Source: SuperGen, Inc.
• On 6:00 am EDT, Thursday October 22, 2009

DUBLIN, Calif.--(BUSINESS WIRE)--SuperGen, Inc. (Nasdaq: SUPG - News), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, will present at the 8^th Annual BIO Investor Forum on October 29, 2009 in San Francisco.

Related Quotes

Symbol	Price	Change
SUPG	2.63	-0.08

{"s" : "supg","k" : "c10,l10,p20,t10","o" : "","j" : ""}

SuperGen's presentation will begin at 9:30 a.m. PT. A live webcast of the presentation will be available on the investor relations section of the Company's Web site at www.supergen.com. The webcast will be archived for 90 days.

About SuperGen

SuperGen is a pharmaceutical company dedicated to the discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit http://www.supergen.com.

Timothy L. Enns
SuperGen, Inc.
Senior Vice President,
Corporate Communications & Business Development
Tel: (925) 560-2810
E-mail: tenns@supergen.com
or
Susanna Chau
SuperGen, Inc.
Manager,
Investor Relations
Tel: (925) 560-2845
E-mail: schau@supergen.com